1.42
1.42 (0%)
As of Apr 17, 2025
Opko Health, Inc. [OPK]
Source:
Company Overview
Opko Health, Inc is a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection.
| Country | United States |
| Headquarters | miami, florida |
| Phone Number | 305-575-4181 |
| Industry | manufacturing |
| CEO | Chairman Of The Board And |
| Website | www.opko.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $713.1 |
| Operating Profit | $-152.1 |
| Net Income | $-53.2 |
| Net Cash | $349.7 |
Profit Ratios
| Gross Margin | $218.5 |
| Operating Margin | -21.3 |
| Profit as % of Revenues | -410.6% |
| Profit as % of Assets | -2.5% |
| Profit as % of Stockholder Equity | -3.9% |
Management Effectiveness
| Return on Equity | -3.9% |
| Return on Assets | -2.4% |
| Turnover Ratio | 33.9% |
| EBITA | $-69.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $2,200.2 |
| Total Liabilities | $834.8 |
| Operating Cash Flow | $-183.5 |
| Investing Cash Flow | $352.2 |
| Financing Cash Flow | $184.2 |
